GSK vs Moderna

GSK (GSK), health care, and Moderna (MRNA), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

GSK is worth $99.1B on the stock market and Moderna $83.9B: GSK is valued at 18% more. GSK's operating margin in its latest fiscal year was 24.3% and Moderna's -158%. Over the past year GSK's share price has moved +6.42% and Moderna's +764%.

Key facts

GSK market value
$99.1B
Moderna market value
$83.9B
GSK P/E
17.2
GSK revenue
$43.4BFY to 2025-12-31
Moderna revenue
$1.9BFY to 2025-12-31
Superinvestors holding both
0

Market values as of .

GSK vs Moderna: every measure side by side
Measure GSK Moderna
SectorHealth CareHealth Care
Country United Kingdom United States
Fiscal year ends2025-12-312025-12-31
Size
Market cap$99.1Bhigher$83.9Blower
Revenue$43.4Bhigher$1.9Blower
Earnings$7.6Bhigher-$2.8Blower
Employees66,841higher4,700lower
Total assets$81.1Bhigher$12.3Blower
Valuation
P/E17.2—
P/S2.3lower43.2higher
P/B—12.3
Dividend yield—0.00%
Profitability
Operating margin24.3%higher-158%lower
Balance sheet
Net assets$21.7Bhigher$8.7Blower
Total liabilities$59.9Bhigher$3.7Blower
Total debt$19.2Bhigher$590Mlower
Cash on hand$4.5Bhigher$2.6Blower
Price change
Today-1.90%higher-3.65%lower
1 year+6.42%lower+764%higher

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Percentages are each holding's share of that investor's reported portfolio. Who owns GSK · Who owns MRNA

Further comparisons

Learn

Questions and answers

Which is bigger, GSK or Moderna?

By market value, GSK is the larger: $99.1B against $83.9B for Moderna. By revenue in its latest fiscal year, GSK is the larger: $43.4B against $1.9B for Moderna.

Which has the higher operating margin?

GSK: 24.3%, against -158% for Moderna. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which has more debt?

GSK: $19.2B, against $590M for Moderna. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

Which superinvestors own both GSK and Moderna?

None of the tracked superinvestors holds both in their latest 13F filing. 11 hold GSK and 2 hold Moderna.

Cite this page

Funkfolio, “GSK vs Moderna”, data as of 17 November 2026. https://funkfolio.com/compare/gsk-vs-mrna

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.